Lionco Pharmaceutical Group Co., Ltd. Class ASSE: 603669

Announcement on the Reply to the Inquiry Letter Regarding Matters Relating to the Earnings Forecast of Lionco Pharmaceutical Group Co., Ltd.

· Issued by Lionco Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Reply to the Inquiry Letter Regarding Matters Relating to the Earnings Forecast of Lionco Pharmaceutical Group Co., Ltd.

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment